When a great victory is needed
LLC "SPC "PHARMASOFT" announces registration of a new dosage of the drug Mexidol® - Mexidol® FORTE 250, film-coated tablets, 250 mg, RU No. LP-004831 of April 26, 2018.
"Mexidol® FORTE 250" is a double dosage of the active ingredient in one film-coated tablet for patients who require an increased dosage, including patients with combined pathology. "Mexidol® FORTE 250" is a reference (original) preparation of ethylmethylhydroxypyridine succinate, the only preparation with active substance ethylmethylhydroxypyridine succinate with a double dosage. "Mexidol® FORTE 250" - a high safety profile.
Presentation of the preparation "Mexidol® FORTE 250" to broad medical community was within the framework of the Xth International Congress "Neurorehabilitation 2018", which was held on May 31 - June 01, 2018 in the building of the Mayor's office of the Moscow Government at the address: Novy Arbat str., 36, at the Simposium "Peculiarities of Management & Rehabilitation of Patients with Comorbid Vascular Diseases", June 01, 9:00-10:30, Sector C.
An influence of submaximal (submineximal) doses of mexidol on oxidant stress and inflammation in the acute period of ischemic stroke
This article is in "Library" section.
Author:
A.R. GODUNOVA, A.A. RAKHIMOVA, O.I. LEONTYEVA, I.G. TALIPOVA, R.M. YAKHIN, SH.G. MUSIN.
Emergency Hospital, Naberezhnye Chelny, Russia.
Modern strategies of protection of hypoxic-ischemic brain damage
This article is in "Library" section.
Author:
S.N. YANISHEVSKY, N.V. TSYGAN, S.YU. GOLOKHVASTOV, R.V. ANDREEV, I.V. LITVINENKO, O.S. KARPOVA, V.A. YAKOVLEVA.
Kirov Military Medical Academy, St. Petersburg, Russia.
Dynamics of eeg and psychophysiological indicators of acute poisoning neurotoxicants on the stage of rehabilitation on the background of different methods of treatment
This article is in "Library" section.
Author:
I.YU. BEREZINA, A.V. BADALYAN, L.I. SUMSKY, YU.S. GOLDFARB
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department, Moscow, Russia;
Russian Medical Academy of Postgraduate Education, Federal Public Educational Institution of Additional Professional Postgraduate Education of Russian Federation Healthcare Ministry, Moscow, Russia
Cytoprotective therapy for kidney injury in patients with ST-elevation myocardial infarction
This article is in "Library" section.
Author:
N.YU. BOROVKOVA1, A.S. ILYINA1, A.A. SPASSKY2, N.N. BOROVKOV1, G.V. KOVALEVA3
Comparative chemoreactome analysis of mexidol
This article is in "Library" section.
Author:
I.YU. TORSHIN, O.A. GROMOVA, I.S. SARDARYAN, L.E. FEDOTOVA
Moscow Institute of Physics and Technology, Dolgoprudny. Russia; Ivanovo State Medical Academy of the RF Ministry of Health, Ivanovo, Russia
Neuroprotection of cerebral accidents in ambulance phase
This article is in "Library" section.
Author:
V. L. RADUSHKEVICH, A. I. OKUNEVSKY
Voronezh State Medical University n. a. N. N. Burdenko, Voronezh, Russia
Characteristics of anxiety in patients of older age groups with different types of mild cognitive disorder
This article is in "Library" section.
Author:
A.P. SIDENKOVA
Urals State Medical University, Ekaterinburg, Russia
A comparative study of the effects of mexidolum and mildronatum on the physical performance of experimental animals
This article is in "Library" section.
Author:
Т.А. VORONINA, I.G. KAPITSA, Е.А. IVANOVA.
Zakusov Institute of Pharmacology, Moscow, Russia.
Mexidol effect on the factor induced by hypoxia HIF-1α expression in the rat cerebral cortex in its ischemia
This article is in "Library" section.
Author:
E.N. YAKUSHEVA, P.YU. MYLNIKOV, I.V. CHERNYKH, A.V. SHCHULKIN.
Pavlov Ryazan State Medical University, Ryazan, Russia.